Effect of cholesterol content in activation of the classical versus the alternative pathway of rat complement system induced by hydrogenated egg phosphatidylcholine-based liposomes

International Journal of Pharmaceutics

Volumn 224, Issue 1-2, 2001, Pages 69-79

  Ishida, Tatsuhiro ^a   Yasukawa, Kazumi ^a   Kojima, Hiroko ^a   Harashima, Hideyoshi ^a   Kiwada, Hiroshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Antibodies; Complement activation; Drug delivery system; Liposomes

Indexed keywords

C REACTIVE PROTEIN; CALCIUM ION; CHOLESTEROL; DOXORUBICIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOSOME; PHOSPHATIDYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL MEMBRANE; CELL COMPOSITION; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; DRUG DELIVERY SYSTEM; EGG; HYDROGENATION; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MEMBRANE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PROTEINS; CHOLESTEROL; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOSOMES; MALE; PHOSPHATIDYLCHOLINES; PHOSPHORIC ACID ESTERS; RATS; RATS, WISTAR;

EID: 0035859987     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00737-2     Document Type: Article

References (32)

1. Safety aspects of pegylated liposomal doxorubicin in patients with cancer
2. Antibodies to cholesterol: Principles for practical application
3. Antibodies to cholesterol, cholesterol conjugates, and liposomes: Implications for atherosclerosis and autoimmunity
4. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes
5. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes
6. The stability and structure of cholesterol-rich codispersions of cholesterol and phosphatidylcholine
7. Liposome-complement interactions in rat serum: Implications for liposome survival studies
8. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma
9. Plasma factor triggering alternative complement pathway activation by liposomes
10. Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats
11. Antigen mobility in membranes and complement-mediated immune attack
12. The complement system enhances the clearance of phosphatidylserine (PS)-liposomes in rat and guinea pig
13. Enhancing effect of cholesterol on the elimination of liposomes from circulation if mediated by complement activation
14. Liposome-induced activation of the classical complement pathway does not require immunoglobulin
15. Complement
16. Molecular organization and function of the complement system
17. Is control of distribution of liposomes between tumors and bone marrow possible?
18. Activation of the alternative complement pathway of guinea-pig by liposomes incorporated with trinitrophenylated phosphatidylethanolamine
19. Effects of cholesterol and cholesterol derivatives on hydrocarbon chain mobility in lipids
20. Use of radiolabelled hexadecyl cholesterol ether as a liposome marker
21. Activation of the complement system by antibody-antigen complexes: The classical pathway
22. Proteins involved in the activation of the classical pathways of human complement
23. Mechanism of transient dyspnea induced by pegylated-liposomal doxorubicin (Doxil)
24. The interaction of liposomes with the complement system
25. Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: Evidence for anti-lipid antibodies and alternative pathway activation
26. The role of complement activation in hypersensitivity to pegylated liposomal doxorubicin (Doxil®)
27. Studies on the hemolytic activity of the classical and alternative pathway of complement in various animal species
28. Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies
29. Complement activation by C-reactive protein complexes
30. Antibodies to liposomal phosphatidylcholine and phosphatidylsulfocholine
31. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids